CHANGMAO BIOCHEM-H-
CHANGMAO BIOCHEM-H- operates in Diversified Metals & Mining.
CHANGMAO BIOCHEM-H- (CZB) - Total Liabilities
Latest total liabilities as of December 2023: €590.91 Million EUR
Based on the latest financial reports, CHANGMAO BIOCHEM-H- (CZB) has total liabilities worth €590.91 Million EUR as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CHANGMAO BIOCHEM-H- - Total Liabilities Trend (2016–2023)
This chart illustrates how CHANGMAO BIOCHEM-H-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CHANGMAO BIOCHEM-H- Competitors by Total Liabilities
The table below lists competitors of CHANGMAO BIOCHEM-H- ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Altern Energy Ltd
KAR:ALTN
|
Pakistan | PKRs6.03 Billion |
|
Marechale Capital Plc
LSE:MAC
|
UK | GBX123.20K |
|
B-Scada Inc
PINK:SCDA
|
USA | $74.72K |
|
Evocati Capital Resources Inc.
V:EVOC-P
|
Canada | CA$15.40K |
|
Atok Big Wedge Co Inc
PSE:AB
|
Philippines | ₱1.23 Million |
|
Distil Plc
LSE:DIS
|
UK | GBX951.00K |
|
Bimi International Medical Inc
OTCMKTS:BIMI
|
USA | $24.15 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down CHANGMAO BIOCHEM-H-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CHANGMAO BIOCHEM-H-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CHANGMAO BIOCHEM-H- (2016–2023)
The table below shows the annual total liabilities of CHANGMAO BIOCHEM-H- from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €590.91 Million | +38.11% |
| 2022-12-31 | €427.86 Million | +65.20% |
| 2021-12-31 | €258.99 Million | +31.19% |
| 2020-12-31 | €197.41 Million | +161.74% |
| 2019-12-31 | €75.42 Million | -25.43% |
| 2018-12-31 | €101.15 Million | -33.20% |
| 2017-12-31 | €151.43 Million | +73.05% |
| 2016-12-31 | €87.50 Million | -- |